Evidence map›Paper›PMID 28230641›Full record

ArticleTransplantation2017

Peritransplant Energy Changes and Their Correlation to Outcome After Human Liver Transplantation.

Bote G Bruinsma, James H Avruch, Gautham V Sridharan, Pepijn D Weeder, Marie Louise Jacobs, Kerry Crisalli, Beth Amundsen, Robert J Porte, James F Markmann, Korkut Uygun and 1 more

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Bote G Bruinsma1 Center for Engineering in Medicine, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 2 Transplant Center, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA. 3 Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
James H Avruch
Gautham V Sridharan
Pepijn D Weeder
Marie Louise Jacobs
Kerry Crisalli
Beth Amundsen
Robert J Porte
James F Markmann
Korkut Uygun
Heidi Yeh
Harvard University · USMassachusetts General Hospital · USUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

Recellularization of Liver BioscaffoldsR01DK084053 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, BASAK ELIF, YARMUSH, MARTIN L · 2009 to 2020
$4.6M
Metabolic Modeling for Cadaveric Organ ResuscitationR01DK096075 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, KORKUT, YEH, HEIDI · 2012 to 2022
$3.9M
Expanding the Liver Transplant Organ Pool through Ex Vivo Liver PerfusionR01DK107875 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MARKMANN, JAMES FRANCIS, UYGUN, KORKUT · 2016 to 2020
$2.8M
Role of B Cells in Transplant ToleranceK08DK094965 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI YEH, HEIDI · 2012 to 2016
$794k
Modeling Human Liver Perfusion Dynamics to Discover Targets for ex vivo Organ TherapyR21EB020819 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, KORKUT · 2016 to 2017
$470k
Expanding the pool of transplantable human livers by modeling perfusion dynamicsF32DK103500 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI SRIDHARAN, GAUTHAM VIVEK · 2014 to 2015
$115k
NIBIB NIH HHS R21 EB020819NIDDK NIH HHS F32 DK103500NIDDK NIH HHS K08 DK094965NIDDK NIH HHS R01 DK084053NIDDK NIH HHS R01 DK096075NIDDK NIH HHS R01 DK107875
6 · The paper itself

Abstract

backgroundThe ongoing shortage of donor livers for transplantation and the increased use of marginal livers necessitate the development of accurate pretransplant tests of viability. Considering the importance energy status during transplantation, we aimed to correlate peritransplant energy cofactors to posttransplant outcome and subsequently model this in an ex vivo setting.

methodsSequential biopsies were taken from 19 donor livers postpreservation, as well as 30 minutes after portal venous reperfusion and hepatic arterial reperfusion and analyzed by liquid chromatography-mass spectrometry for energetic cofactors (adenosine triphosphate [ATP]/adenosine diphosphate [ADP]/adenosine monophosphate [AMP], nicotinamide adenine dinucleotide /NAD, nicotinamide adenine dinucleotide phosphate / nicotinamide adenine dinucleotide phosphate , flavin adenine dinucleotide , glutathione disulfide/glutathione). Energy status was correlated to posttransplant outcome. In addition, 4 discarded human donation after circulatory death livers were subjected to ex vivo reperfusion, modeling reperfusion injury and were similarly analyzed for energetic cofactors.

resultsA rapid shift toward higher energy adenine nucleotides was observed following clinical reperfusion, with a 2.45-, 3.17- and 2.12-fold increase in ATP:ADP, ATP:AMP and energy charge after portal venous reperfusion, respectively. Seven of the 19 grafts developed early allograft dysfunction. Correlation with peritransplant cofactors revealed a significant difference in EC between early allograft dysfunction and normal functioning grafts (0.09 vs 0.31, P < 0.05). In the simulated reperfusion model, a similar trend in adenine nucleotide changes was observed.

conclusionsA preserved energy status appears critical in the peritransplant period. Levels of adenine nucleotides change rapidly after reperfusion and ratios of ATP/ADP/AMP after reperfusion are significantly correlated to graft function. Using these markers as a viability test in combination with ex vivo reperfusion may provide a useful predictor of outcome that incorporates donor, preservation, and reperfusion factors.

Indexed as

Energy MetabolismAdenine NucleotidesAdolescentAdultAgedBiomarkersBiopsyCytokinesFemaleHumansInflammation MediatorsLiverLiver TransplantationMaleMiddle AgedPerfusionAdenine NucleotidesBiomarkersCytokinesInflammation Mediators

Identifiers

PMID28230641
PMCPMC5481470
OpenAlexW2591141971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.